INTERNATIONAL MEETING OF WORLD PHARMACOPOEIAS 29 February to 2 March 2012 WHO, Geneva 1.

Slides:



Advertisements
Similar presentations
Animal Experimentation – an Introduction Made in the interest of Animals by FIAPO. Please direct any queries to Alokparna Sengupta at
Advertisements

HTA from an Industry Perspective Janey Shin, Director of Medical Affairs Johnson & Johnson Medical Companies CADTH, 2015.
SOURCES OF PHARMACEUTICAL INFORMATION. 1-Pharmacopeias Pharmacopoeia is a book containing an official list of the drugs used in medicine together with.
Introduction to the Manufacturing Science and Engineering section of AAPS and Careers in the Pharmaceutical and Biotech Industries SPEAKER NAME SPEAKER.
Nanotechnology in India Krishna Ravi Srinivas RIS GEST Project Meeting, Preston 16 th March 2012.
“SHOW CASING A.P.” FAPCCI Seminar on “Meeting Global Outsourcing Requirement” PRESENTATION By DR.P.V.APPAJI M.Pharm, Ph.D EXECUTIVE DIRECTOR PHARMEXCIL.
Lecture – DR. SHAHNAZ USMAN Associate Professor Dept. of Pharmaceutics RAKMHSU PHARMACOPOEIAS AND OTHER OFFICIAL COMPENDIA 1.
Why Pharmacy? “Indian pharmaceutical Industry is one of the world’s largest and most developed”
Traditional & Complementary Medicine in Malaysia [International Conclave on Traditional Medicine, New Delhi, INDIA Nov. 2006] Datuk Dr. M.S. Pillay.
Association of Pharmaceutical Companies Representatives in Georgia APCRG, WASHINGTON DC, February
Inspired from Life Vision “To be most admired Scientifically driven Global Player in Next Generation Pharmaceutical & wellness Industry in 10 Years”
RPS Publishing Dr. Laszlo Horvath. Overview Brief History Brief History RPS Publishing – Imprints RPS Publishing – Imprints Pharmaceutical Press Products.
STRATEGIC MANAGEMENT 1 Irina Raynaud Pierre Jean Tessier Nicolas Cabrit Clément Tumoine.
Pharmacovigilance Programme of India
1 32nd WHO South-East Asia Advisory Committee on Health Research Bangkok, Thailand, October 2011 Review of work carried out by Subcommittee on Vaccines.
NEW EDITION OF IP : THE IP 2007 By Dr G N Singh Secretary-cum- Scientific Director Indian Pharmacopoeia Commission Ghaziabad.
( An IACBE Accredited Institution ) Industry Analytics Post Graduate Programme (2010 – 12) 3rd Term Alliance Business School Bangalore.
CORPORATE SOCIAL RESPOSIBILITY PRESENTED BY – D SHREE VENKATESH –
Veiovis LifeSciences Pvt Ltd
DMF Procedures and Communication between API, FP Manufacturers and Regulatory Authorities Jean-Louis ROBERT National Health Laboratory L – 1011 LUXEMBOURG.
Monograph Development Process for the European Pharmacopoeia: How to participate in the work programme of the European Pharmacopoeia Dr Claude Coune Head.
Regulation of medicines and other health technologies. The future of regulation, where are we going? EMP TBS November 2014, Geneva Dr Lembit Rägo Head,
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
Pharmacovigilance of Nutraceutical Products
CD ROMs for Pharmaceutical use Patrick Bongo BSc (Hons), MSc, PGCE, MBCS.
Dr Saranjit Singh National Institute of Pharmaceutical Education and Research SAS Nagar India Setting Impurity Standards for.
HERBALS IN PHARMACY: CHALLENGES Zhari Ismail PhD (U of Strathclyde) Pharmaceutical Chemistry Discipline School of Pharmaceutical Sciences Universiti Sains.
Current issues and challenges in the development of IP monographs Dr. G.N. Singh Secretary-cum-Scientific Director Indian Pharmacopoeia Commission Ghaziabad.
INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT. INDIAN PHARMACOPOEIA MONOGRAPH DEVELOPMENT Indian Pharmacopoeia Commission (IPC) Vision The IPC is committed.
THE 9TH ASIA-PACIFIC CO-OPERATIVE MINISTER’S CONFERENCE. ENABLING CO-OPERATIVE LEGAL AND POLICY ENVIROMENT FOR “SUFFICIENCY ECONOMI” IN ACHIEVING THE.
FORMATION AND FUNCTIONING OF INDIAN PHARMACOPOEIA COMMISSION (IPC) By Dr G N Singh Member-Secretary.
State Pharmacopoeia of Ukraine: present and future Maryna Dmitriieva Scientific Secretary of Ukrainian Scientific Pharmacopoeial Centre for Quality of.
Anthony Serracino Inglott Chairman of the Malta Medicines Authority
National Coalition for Sustained Iodine Intake (NCSII)
Global Healthcare CMO Market: Trends & Opportunities ( ) Tel:
GMP- A Regulatory Perspective. Regulatory Perspective in entering Global Pharma Markets.
IPEC Overview The Impact of Globalisation and IPEC’s Role Janeen Skutnik Past Chair – IPEC Americas.
Indian Clinical Trials- The Unaddressed Challenges of Regulatory Amendments Dr. N. Srinivas Principal Malla Reddy Institute of Pharmaceutical Sciences.
Quality Assurance of Medicines under Universal Health Coverage Program by Siriwat Tiptaradol (Presenter) Duangporn Abhigantaphand Sooksri Ungboriboonpisal.
1. BIOPHARMACEUTICAL Korea Where Success Knows No Limits 2 Index 1. Industry Overview3 2. Competitive Standing and Outlook9 3. Government Policies14 4.
PHARMACOPOEIA. Pharmacopoeia The term Pharmacopoeia comes from the Greek word “Pharmakon” meaning ‘drug’ and ‘Poiein’ meaning ‘make’, and the combination.
Warm-up While working at the Rest Haven Rehab Center, you walk into Mrs. Jones room to help her prepare for supper. Mrs. Jones is lying in the bed with.
Aarkstore - Metastatic Ovarian Cancer- Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Category : Pharmaceuticals and Healthcare.
INDEX WHAT IS ICH ? HISTORY INITIATION INTRODUCTION TOPICS QUALITY GUDILINES.
Interesting Facts about Pharmaceutical industry
PHARMA HELPLINE SOCIETY we care,we assist, we help Announces on line courses for the overall development of pharmacy professionals and students. These.
Water Testing Labs in Chennai
PRESENTED BY : MR. P. R. KODAPE.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Mammalian Cells Bioreactor Market to reach $1.5 bn by 2024
HIMSS Standards Activities
- Pharmaceutical Equivalence Study
Health System Financing in Odisha
REGISTRATION OF CERTIFIED PUBLIC SECRETARIES BOARD (RCPSB)
Krishna Chemical: Best Chemical & Liquid Logistics Service Industry.
Pharmaceutical Excipients Market Opportunity Analysis and Industry Forecast,
راهنماي اختصاصي اخلاق در كارآزمايي هاي باليني
Best Fashion Photographer in Delhi More info- photographer-in-india-top-indian-photographer/
Career Opportunities In Pharmacy. What is Pharmacy Pharmacy is the science and technique of preparing, researching, and distributing medicinal drugs.
PHARMACOPOEIA Dr Md Yousuf Ansari MMCP Mullana.
Introduction to TransCelerate
Drug regulation and quality assurance:
Vigilance of medical devices and IVDs in the South East Asia Region –Safety Monitoring Systems in India and other Countries Dr. Madhur Gupta; MD, DM Technical.
Standardization on Medical Devices
Medical Device Safety: India’s Perspective
The Next Frontier for Public Health Medicines Market
Order Natural Herbs Online. B uy Herbs Online. We offer the most extensive selection of certified organic Herbal Products at Low Prices In India.
The European Pharmacopoeia and Pharmeuropa
Achieving Sustainable API Production in Africa
GMP and Pharmacopoeia: Harmonisation of Basic Regulators’ Tools
Global Specialty Pharmaceuticals Market. Report Description and Highlights According to Renub Research report "Specialty Pharmaceuticals Market, by Country.
Presentation transcript:

INTERNATIONAL MEETING OF WORLD PHARMACOPOEIAS 29 February to 2 March 2012 WHO, Geneva 1

2

Indian Pharmacopoeia Commission The Indian Pharmacopoeia Commission is the Standards Setting Institution for Drugs in India. It is an autonomous body under the Ministry of Health & Family Welfare, Govt. of India, New Delhi. 3

Indian Pharmacopoeia Commission Vision Topromotethehigheststandards ofdrugsfor use in humans and animals within practical limits ofthe technologiesavailablefor manufacturing and analysis. Mission TopromotepublichealthinIndia bybringing outauthoritativeandofficiallyaccepted standards for quality of drugs including APIs, excipients and dosage forms, used by health professionals, patients and consumers. 4

Mandates of the Commission Publication of Indian Pharmacopoeia the book of standards for Drugs in India Bringing out the National Formulary of India, the reference book for healthcare professionals Providing IP Reference Substances Nodal agencyforestablishingnational/ internationalcollaborationwithsimilarlyplaced bodies 5

Highlights of 6 th Edition IP

IP Herbal Monographs Monographs on herbs and herbal products in IP 2010 include color photograph of crude drugs and TLC/ HPLC/HPTLC chromatogram IP also provided the specifications /details: oForeign organic matter oEthanol soluble extractive oWater soluble extractive oTotal ash and Acid-insoluble ash, oHeavy metal content oLoss on drying, oMicrobial limits/contamination, oAssay method by HPLC/HPTLC/TLC 7

Trends of Herbs and Herbal Products Monographs in IP 8 Monographs IP 1955 IP 1966 IP 1985 IP 1996 IP 2007 IP 2010 Crude drugs Extracts Finished formulations Pharmaceutical aid

Trends of Biopharmaceuticals Monographs in IP 9 Monographs IP 1966 IP 1985 IP 1996 IP 2007 IP 2010 Vaccines & immunosera for Human use Diagnostics for Human use Blood & Blood related Products Biotechnological product 00055

Government Initiatives 10

Industry Perspective 11

Challenges Sharing of information among Pharmacopoeias? o Resources o Working in pockets where there is need for sharing information o Commitment  Let’s begin top 20 selling molecules to service humanity  Monitoring  Harmonization with leading pharmacopoeias 12

Way Forward Toprovide‘Quality harmonized‘Drug monitoringqualityof Medicines’through Standards’and medicinesthrough effective ‘Regulatory System’ 13

International vision with an approach to make IP Standards globally recognized 14